FFCP PHASE1:Hg19::chr13:37363331..37363344,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr13:37363331..37363344,- | |||
|coexpression_cluster_id=C125 | |||
|description=CAGE_peak_at_chr13:37363331..37363344,- | |||
|id=chr13:37363331..37363344,- | |||
|ontology_enrichment_celltype=CL:0000159!1.26e-20!2;CL:0002149!2.58e-15!6;CL:0002255!2.58e-15!6;CL:0000319!2.53e-11!1;CL:0000313!4.58e-11!1;CL:0000569!2.48e-10!4;CL:0000011!2.48e-10!4;CL:0002322!2.00e-08!5 | |||
|ontology_enrichment_celltype_v019=CL:0000319;6.62e-41;1!CL:0002149;2.91e-27;6!CL:0002255;2.91e-27;6!CL:0000159;3.11e-21;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000319,6.62e-41,1;CL:0002149,3.11e-27,6;CL:0002255,3.11e-27,6;CL:0000159,3.11e-21,2 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:3001!2.58e-15!6;DOID:299!1.04e-13!25;DOID:193!1.34e-11!29;DOID:3030!2.53e-11!1;DOID:2152!4.58e-11!1;DOID:2355!1.77e-10!1;DOID:120!6.05e-09!27 | |||
|ontology_enrichment_disease_v019=DOID:3030;6.62e-41;1!DOID:3001;2.91e-27;6!DOID:299;6.54e-26;25!DOID:4468;6.30e-21;2!DOID:120;5.66e-14;27!DOID:193;4.54e-13;29 | |||
|ontology_enrichment_disease_v019_2=DOID:3030,6.62e-41,1;DOID:3001,3.11e-27,6;DOID:299,6.54e-26,25;DOID:4468,5.70e-21,2;DOID:120,5.66e-14,27;DOID:193,4.54e-13,29;DOID:305,5.66e-10,106;DOID:0050687,1.55e-07,143 | |||
|ontology_enrichment_uberon=UBERON:0000473!3.78e-11!8;UBERON:0004911!4.58e-11!1;UBERON:0003133!4.31e-09!48;UBERON:0003135!3.00e-08!11;UBERON:0000991!2.02e-07!21;UBERON:0009196!2.02e-07!21;UBERON:0009117!2.02e-07!21;UBERON:0005564!2.02e-07!21;UBERON:0005156!2.93e-07!59;UBERON:0000990!2.93e-07!59;UBERON:0004176!4.32e-07!22 | |||
|ontology_enrichment_uberon_v019=UBERON:0000995;2.40e-10;17!UBERON:0003975;7.93e-10;18!UBERON:0004175;1.45e-08;21 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000995,1.48e-08,21;UBERON:0005795,3.27e-08,22;UBERON:0003975,3.27e-08,22;UBERON:0004175,2.43e-07,25 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.196468613246569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.264818361626438,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.10366105501537,0.252320850875628,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.301439377059586,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307160702099232,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.46909527343233,0,0,0,0,0,0,0,0.104421949505455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.83062910471503,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.160317640503067,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.228840068396924,0,0,0.147855149989634,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.4160597915438,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.83004496290278,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.24082554265728,0.955538938977433,0.335566295393377,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.101988829741982,0,0,0,0.227336094654718,0.267964130156178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr13:37363331..37363344,- | |||
}} |
Latest revision as of 15:50, 24 July 2015
Short description: | p@chr13:37363331..37363344, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr13:37363331..37363344, - |
Coexpression cluster: | C125_mucinous_alveolar_mesothelioma_Smooth_lung_CD14_Nucleus |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mucus secreting cell | 6.62e-41 | 1 |
epithelial cell of uterus | 3.11e-27 | 6 |
stromal cell of endometrium | 3.11e-27 | 6 |
seromucus secreting cell | 3.11e-21 | 2 |
Ontology term | p-value | n |
---|---|---|
uterus | 1.48e-08 | 21 |
embryonic uterus | 3.27e-08 | 22 |
internal female genitalia | 3.27e-08 | 22 |
internal genitalia | 2.43e-07 | 25 |
Ontology term | p-value | n |
---|---|---|
mucinous adenocarcinoma | 6.62e-41 | 1 |
female reproductive endometrioid cancer | 3.11e-27 | 6 |
adenocarcinoma | 6.54e-26 | 25 |
clear cell adenocarcinoma | 5.70e-21 | 2 |
female reproductive organ cancer | 5.66e-14 | 27 |
reproductive organ cancer | 4.54e-13 | 29 |
carcinoma | 5.66e-10 | 106 |
cell type cancer | 1.55e-07 | 143 |